Dr. Tahir Yahya is a distinguished medical expert specializing in diagnostics, with medical training in Internal Medicine and Nuclear Medicine. He has a comprehensive background in molecular diagnostics, companion diagnostics (CDx), healthcare management, and patient safety.

Currently, he serves as the Chief Medical Officer at Nutromics, an innovative med tech start-up in Australia. Previously, Dr. Yahya held key roles at Abbott, working in both the Molecular and Core Diagnostics divisions. He specialized in Clinical Chemistry, Immunoassays, and high-throughput diagnostic analyzers. At Abbott, he played a critical role in Risk Management Assessment and Post Market Surveillance, ensuring the safety and efficacy of diagnostic products. His leadership and expertise drive advancements in medical diagnostics, aiming to improve healthcare outcomes globally by integrating cutting-edge healthcare and technology.